Form 8-K - Current report:
SEC Accession No. 0000950170-25-076374
Filing Date
2025-05-22
Accepted
2025-05-22 16:30:21
Documents
10
Period of Report
2025-05-21
Items
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K evok-20250521.htm   iXBRL 8-K 94083
  Complete submission text file 0000950170-25-076374.txt   198033

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT evok-20250521.xsd EX-101.SCH 23903
12 EXTRACTED XBRL INSTANCE DOCUMENT evok-20250521_htm.xml XML 4534
Mailing Address 420 STEVENS AVENUE SUITE 230 SOLANA BEACH CA 92075
Business Address 420 STEVENS AVENUE SUITE 230 SOLANA BEACH CA 92075 858-345-1494
Evoke Pharma Inc (Filer) CIK: 0001403708 (see all company filings)

EIN.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36075 | Film No.: 25977596
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)